Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF ANTI-DILUTIVE EFFECT (Details)

v3.23.2
SCHEDULE OF ANTI-DILUTIVE EFFECT (Details) - shares
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 5,001,276 827,101 5,001,276 827,101
Equity Option [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 304,164 403,911 304,164 403,911
Restricted Stock [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 10,455 28,613 10,455 28,613
Warrant [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total 4,686,657 394,577 4,686,657 394,577